Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.7768

-0.0429 (-5.23%)

At close: May 12, 2025, 4:00 PM

0.7600

-0.0168 (-2.16%)

After-hours: May 12, 2025, 7:52 PM EDT

RVPH Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Net Income	-29.92	-39.26	-28.26	-8.52	-3.78	Upgrade
Depreciation & Amortization	-	-	-	-	0	Upgrade
Stock-Based Compensation	1.63	3.41	0.18	0.15	-	Upgrade
Other Operating Activities	-0.72	0.24	0.19	-1.59	2.05	Upgrade
Change in Accounts Payable	2.29	0.33	3.01	-0.5	0.78	Upgrade
Change in Other Net Operating Assets	-6.83	6.96	5.92	-0.2	-3.1	Upgrade
Operating Cash Flow	-33.54	-28.32	-18.96	-10.67	-4.07	Upgrade
Short-Term Debt Issued	0.98	0.67	-	-	3.11	Upgrade
Total Debt Issued	0.98	0.67	-	-	3.11	Upgrade
Short-Term Debt Repaid	-0.52	-0.67	-	-	-	Upgrade
Total Debt Repaid	-0.52	-0.67	-	-	-	Upgrade
Net Debt Issued (Repaid)	0.46	-	-	-	3.11	Upgrade
Issuance of Common Stock	23.19	33.17	7.79	31.6	9.72	Upgrade
Financing Cash Flow	23.65	33.17	7.79	31.6	12.83	Upgrade
Net Cash Flow	-9.89	4.85	-11.17	20.93	8.76	Upgrade
Cash Interest Paid	0.02	0.03	-	-	0.33	Upgrade
Cash Income Tax Paid	0	0.02	-	0	0	Upgrade
Levered Free Cash Flow	-21.54	-14.01	-8.54	-6.87	-4.15	Upgrade
Unlevered Free Cash Flow	-21.52	-13.99	-8.54	-6.87	-3.24	Upgrade
Change in Net Working Capital	3.91	-7.28	-8.93	0.7	1.72	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q